| Overview |
| bsm-62053r-cy3-100ul |
| Glucagon Recombinant Antibody, Cy3 Conjugated |
| WB, IF |
| Human, Mouse, Rat |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Glucagon |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 2641 |
| P01275 |
| Secreted |
| GCG; Glicentin; Glicentin-related polypeptide; GLP-1;; GLP-2; GLP1; GLP2; GLUC; Glucagon; GRPP; OXM; OXY. |
| Glucagon: Plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes. |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
|